PT920426E - Novos derivados de tiazole com efeito inibidor de fosfodiesterase - Google Patents
Novos derivados de tiazole com efeito inibidor de fosfodiesteraseInfo
- Publication number
- PT920426E PT920426E PT97940080T PT97940080T PT920426E PT 920426 E PT920426 E PT 920426E PT 97940080 T PT97940080 T PT 97940080T PT 97940080 T PT97940080 T PT 97940080T PT 920426 E PT920426 E PT 920426E
- Authority
- PT
- Portugal
- Prior art keywords
- new
- phosphodiesterase inhibitor
- pct
- inhibitor effect
- tiazole
- Prior art date
Links
- 229940099471 Phosphodiesterase inhibitor Drugs 0.000 title 1
- 239000002571 phosphodiesterase inhibitor Substances 0.000 title 1
- 229940124639 Selective inhibitor Drugs 0.000 abstract 1
- 102000011017 Type 4 Cyclic Nucleotide Phosphodiesterases Human genes 0.000 abstract 1
- 108010037584 Type 4 Cyclic Nucleotide Phosphodiesterases Proteins 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19634411 | 1996-08-26 | ||
| EP96113737 | 1996-08-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT920426E true PT920426E (pt) | 2004-02-27 |
Family
ID=26028746
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT97940080T PT920426E (pt) | 1996-08-26 | 1997-08-13 | Novos derivados de tiazole com efeito inibidor de fosfodiesterase |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6011037A (pt) |
| EP (1) | EP0920426B9 (pt) |
| JP (1) | JP2000516940A (pt) |
| AT (1) | ATE251153T1 (pt) |
| AU (1) | AU4205197A (pt) |
| CY (1) | CY2509B1 (pt) |
| DE (1) | DE59710816D1 (pt) |
| DK (1) | DK0920426T3 (pt) |
| ES (1) | ES2208950T3 (pt) |
| PT (1) | PT920426E (pt) |
| SI (1) | SI0920426T1 (pt) |
| WO (1) | WO1998008841A1 (pt) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU229439B1 (hu) | 1999-08-21 | 2013-12-30 | Takeda Gmbh | Roflumilast és salmeterol szinergetikus kombinációja |
| PL210475B1 (pl) | 2001-08-13 | 2012-01-31 | Janssen Pharmaceutica Nv | Pochodna 2,4,5-tripodstawionego tiazolilu, sposób jej wytwarzania i zastosowanie oraz kompozycja farmaceutyczna i sposób jej wytwarzania |
| CA2620333A1 (en) | 2005-08-26 | 2007-03-01 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
| EP2258357A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis with acetylcholinesterase inhibitor |
| WO2007047978A2 (en) | 2005-10-21 | 2007-04-26 | Braincells, Inc. | Modulation of neurogenesis by pde inhibition |
| EP2314289A1 (en) | 2005-10-31 | 2011-04-27 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
| US20100216734A1 (en) * | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| US20070244143A1 (en) * | 2006-03-08 | 2007-10-18 | Braincells, Inc | Modulation of neurogenesis by nootropic agents |
| CA2651813A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
| US20100009983A1 (en) * | 2006-05-09 | 2010-01-14 | Braincells, Inc. | 5 ht receptor mediated neurogenesis |
| US7678808B2 (en) * | 2006-05-09 | 2010-03-16 | Braincells, Inc. | 5 HT receptor mediated neurogenesis |
| EP2068872A1 (en) * | 2006-09-08 | 2009-06-17 | Braincells, Inc. | Combinations containing a 4-acylaminopyridine derivative |
| US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
| CA2663347A1 (en) * | 2006-09-19 | 2008-03-27 | Braincells, Inc. | Ppar mediated modulation of neurogenesis |
| WO2010099217A1 (en) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
| EP2706852B1 (en) | 2011-05-10 | 2018-08-22 | Merck Sharp & Dohme Corp. | Bipyridylaminopyridines as syk inhibitors |
| JP2014513686A (ja) | 2011-05-10 | 2014-06-05 | メルク・シャープ・アンド・ドーム・コーポレーション | Ｓｙｋ阻害薬としてのアミノピリミジン |
| EP2707357B1 (en) | 2011-05-10 | 2017-01-18 | Merck Sharp & Dohme Corp. | Pyridyl aminopyridines as syk inhibitors |
| WO2013106547A1 (en) | 2012-01-10 | 2013-07-18 | President And Fellows Of Harvard College | Beta-cell replication promoting compounds and methods of their use |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2245660T3 (es) * | 1990-11-30 | 2006-01-16 | Otsuka Pharmaceutical Co., Ltd. | Derivados de azol y su utilizacion como inhibidores de los radicales superoxidos. |
| AU657413C (en) * | 1992-05-29 | 2007-05-03 | Otsuka Pharmaceutical Co., Ltd. | Thiazole derivatives for the release of superoxide radical |
| GB9315017D0 (en) * | 1993-07-20 | 1993-09-01 | Glaxo Lab Sa | Chemical compounds |
| JPH10504542A (ja) * | 1994-07-27 | 1998-05-06 | ジー．ディー．サール アンド カンパニー | 炎症処置用の置換チアゾール化合物 |
-
1997
- 1997-08-13 AT AT97940080T patent/ATE251153T1/de not_active IP Right Cessation
- 1997-08-13 JP JP10511228A patent/JP2000516940A/ja active Pending
- 1997-08-13 ES ES97940080T patent/ES2208950T3/es not_active Expired - Lifetime
- 1997-08-13 SI SI9730611T patent/SI0920426T1/xx unknown
- 1997-08-13 AU AU42051/97A patent/AU4205197A/en not_active Abandoned
- 1997-08-13 WO PCT/EP1997/004435 patent/WO1998008841A1/de active IP Right Grant
- 1997-08-13 EP EP97940080A patent/EP0920426B9/de not_active Expired - Lifetime
- 1997-08-13 DK DK97940080T patent/DK0920426T3/da active
- 1997-08-13 US US09/147,740 patent/US6011037A/en not_active Expired - Fee Related
- 1997-08-13 DE DE59710816T patent/DE59710816D1/de not_active Expired - Fee Related
- 1997-08-13 PT PT97940080T patent/PT920426E/pt unknown
-
2005
- 2005-03-23 CY CY0500019A patent/CY2509B1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0920426A1 (de) | 1999-06-09 |
| DE59710816D1 (de) | 2003-11-06 |
| AU4205197A (en) | 1998-03-19 |
| EP0920426B9 (de) | 2005-04-06 |
| WO1998008841A1 (de) | 1998-03-05 |
| SI0920426T1 (en) | 2004-04-30 |
| DK0920426T3 (da) | 2004-02-02 |
| CY2509B1 (en) | 2005-12-23 |
| ES2208950T3 (es) | 2004-06-16 |
| ATE251153T1 (de) | 2003-10-15 |
| US6011037A (en) | 2000-01-04 |
| EP0920426B1 (de) | 2003-10-01 |
| JP2000516940A (ja) | 2000-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT920426E (pt) | Novos derivados de tiazole com efeito inibidor de fosfodiesterase | |
| ATE233247T1 (de) | Phtalazinonen | |
| DK0937074T3 (da) | Benzonaphthyridiner som bronkiale terapeutiske midler | |
| SI1070056T1 (en) | Phthalazinone pde iii/iv inhibitors | |
| DE69115280D1 (de) | Indolderivate, die die leukotrienbiosynthese hemmen. | |
| DK1000035T3 (da) | Substituerede 6-phenylphenanthridiner | |
| DE69719358D1 (de) | Substituierte dihydrobenzofurane als pde-hemmstoffe | |
| IL122737A (en) | Salts of amidine derivatives and cyclooxygenase inhibitors, their preparation and pharmaceutical compositions containing them | |
| GB2324091B (en) | Metalloproteinase inhibitors | |
| PT1003724E (pt) | Derivados substituidos com accao antiviral | |
| SI0937075T1 (en) | New Imidazo- and Oxazolopyridines as Phosphodiesterase Inhibitors. |